CLINICAL_TRIALS
trial_result
· 2015-10-15
Clinical Trial Update: Safety Study of Apixaban in Recent Acute Coronary Syndrome [Phase 2]
Summary
Phase 2 safety study of apixaban in patients with recent acute coronary syndrome completed; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Acute Coronary Syndrome (ACS) | Phase 2 | Status: COMPLETED | Results posted: 2015-10-15